# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001437749-23-008519
Filing Date
2023-03-30
Accepted
2023-03-30 08:50:43
Documents
49
Period of Report
2023-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | dffn20230329_8k.htm iXBRL | 8-K | 69022
2 | EXHIBIT 2.1 | ex_494918.htm | EX-2.1 | 874880
3 | EXHIBIT 10.1 | ex_494896.htm | EX-10.1 | 124458
4 | EXHIBIT 10.2 | ex_494897.htm | EX-10.2 | 41369
5 | EXHIBIT 10.3 | ex_494898.htm | EX-10.3 | 12227
6 | EXHIBIT 10.4 | ex_494899.htm | EX-10.4 | 11644
7 | EXHIBIT 10.5 | ex_494900.htm | EX-10.5 | 13061
8 | EXHIBIT 99.1 | ex_494901.htm | EX-99.1 | 70994
9 | EXHIBIT 99.2 | ex_494916.htm | EX-99.2 | 37322
10 | EXHIBIT 99.3 | ex_494917.htm | EX-99.3 | 15649
15 |  | d01.jpg | GRAPHIC | 4321
16 |  | d02.jpg | GRAPHIC | 3632
17 |  | d9_page01.jpg | GRAPHIC | 67594
18 |  | d9_page02.jpg | GRAPHIC | 154280
19 |  | d9_page03.jpg | GRAPHIC | 122393
20 |  | d9_page04.jpg | GRAPHIC | 101539
21 |  | d9_page05.jpg | GRAPHIC | 135234
22 |  | d9_page06.jpg | GRAPHIC | 91365
23 |  | d9_page07.jpg | GRAPHIC | 131497
24 |  | d9_page08.jpg | GRAPHIC | 121637
25 |  | d9_page09.jpg | GRAPHIC | 178853
26 |  | d9_page10.jpg | GRAPHIC | 133528
27 |  | d9_page11.jpg | GRAPHIC | 148936
28 |  | d9_page12.jpg | GRAPHIC | 129239
29 |  | d9_page13.jpg | GRAPHIC | 130294
30 |  | d9_page14.jpg | GRAPHIC | 124657
31 |  | d9_page15.jpg | GRAPHIC | 132239
32 |  | d9_page16.jpg | GRAPHIC | 147968
33 |  | d9_page17.jpg | GRAPHIC | 128423
34 |  | d9_page18.jpg | GRAPHIC | 127012
35 |  | d9_page19.jpg | GRAPHIC | 94937
36 |  | d9_page20.jpg | GRAPHIC | 109339
37 |  | d9_page21.jpg | GRAPHIC | 105526
38 |  | d9_page22.jpg | GRAPHIC | 60815
39 |  | rider01.jpg | GRAPHIC | 201266
40 |  | rider02.jpg | GRAPHIC | 212673
41 |  | rider03.jpg | GRAPHIC | 80573
| Complete submission text file | 0001437749-23-008519.txt |  | 6041242

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20230329.xsd | EX-101.SCH | 3602
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20230329_def.xml | EX-101.DEF | 11533
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20230329_lab.xml | EX-101.LAB | 15415
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20230329_pre.xml | EX-101.PRE | 11689
43 | EXTRACTED XBRL INSTANCE DOCUMENT | dffn20230329_8k_htm.xml | XML | 2594

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 23777351
SIC: 2834 Pharmaceutical Preparations